Compare NUTX & ARAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NUTX | ARAY |
|---|---|---|
| Founded | 2011 | 1990 |
| Country | United States | United States |
| Employees | 944 | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 31.3M |
| IPO Year | 2009 | 2006 |
| Metric | NUTX | ARAY |
|---|---|---|
| Price | $216.70 | $0.25 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 2 |
| Target Price | ★ $252.50 | $3.50 |
| AVG Volume (30 Days) | 111.3K | ★ 497.6K |
| Earning Date | 04-30-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 7.93 | ★ 87.50 |
| EPS | ★ 15.87 | N/A |
| Revenue | ★ $875,257,000.00 | N/A |
| Revenue This Year | $6.12 | N/A |
| Revenue Next Year | $4.04 | $4.58 |
| P/E Ratio | $12.62 | ★ N/A |
| Revenue Growth | ★ 82.36 | N/A |
| 52 Week Low | $83.99 | $0.22 |
| 52 Week High | $204.00 | $2.10 |
| Indicator | NUTX | ARAY |
|---|---|---|
| Relative Strength Index (RSI) | 62.32 | 40.39 |
| Support Level | $142.71 | $0.23 |
| Resistance Level | $204.00 | $0.33 |
| Average True Range (ATR) | 9.32 | 0.02 |
| MACD | -0.06 | -0.00 |
| Stochastic Oscillator | 90.56 | 12.33 |
Nutex Health Inc is a physician-led, healthcare services and operations company with various hospital facilities in the U.S. states (hospital division), and a primary care-centric, risk-bearing population health management division. The company has three segments: the hospital division, the PHM division, and the real estate division. The hospital division implements and operates health care models, including micro-hospitals, specialty hospitals and hospital outpatient departments (HOPDs). The population health management (PHM) division owns and operates provider networks such as independent physician associations (IPAs). The Real Estate Entities own the land and hospital buildings which are leased to its hospital entities. The majority of the revenue is derived from the Hospital division.
Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, treatment solutions which set the standard of radiation therapy care with the objective of helping patients live lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention. The company has one operating segment which develops, manufactures and markets proprietary medical devices used in radiation therapy for the treatment of cancer patients.